Related Experiment Video
Updated: Oct 20, 2025
05:32
In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
Published on: February 16, 2024
600
The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies
Hermann Einsele1, Javier Briones2, Fabio Ciceri3
1Department of Internal Medicine II, University Hospital Würzburg, Germany.
Hemasphere
|September 15, 2021
Summary
The European Hematology Association (EHA) updated its research roadmap, identifying key priorities in hematology research and clinical science to guide future advancements and funding in blood disorder studies.
Area of Science:
- Hematology research
- Clinical science
- Blood disorders
Background:
- The European Hematology Association (EHA) initially published its roadmap in 2016 to outline achievements and needs in hematology.
- Significant advancements in hematology necessitate an updated roadmap to reflect current priorities.
Discussion:
- The updated EHA Research Roadmap encompasses 11 distinct sections, each addressing critical areas within hematology.
- This comprehensive update aims to inform policymakers and stakeholders about urgent research and clinical needs.
Key Insights:
- The roadmap identifies the most pressing priorities in hematology research and clinical science.
- It covers a broad spectrum of hematological conditions, from normal hematopoiesis to advanced therapies like CAR-T and gene therapy.
Outlook:
- The updated roadmap will support a more informed, focused, and potentially better-funded future for European Hematology Research.
- Publication of the 11 sections will provide detailed guidance for researchers and clinicians.
Related Concept Videos
01:01Regulation of Hematopoietic Stem Cells
3.5K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.5K
01:22Bone Marrow Sampling and Transplants
579
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
579
01:21Stem Cell Therapy for Tissue Regeneration
4.3K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.3K
01:28Role of Hematopoietic Growth Factors
1.9K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.9K
01:21Hematopoiesis
7.1K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
7.1K
01:27Tumor Immunotherapy
746
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
746